ghk-cu injektion dosierung MCCM DoNotAge Kupferpeptid Frage zur Dosierung von GHK-CU-Vials
Description
It can also interact with cannabinoid receptors and, through inhibition of fatty acid amide hydrolase (FAAH), which metabolizes the endocannabinoid anandamide, activate antinociceptive pathways [96]
Do you have any neurological symptoms eg tingling, pins and needles, memory problems, balance issues, tinnitus, tremors etc
While these applications remain preclinical, they illustrate the broad regenerative potential of this peptide and explain why TB-500 features in so many multi-tissue recovery protocols
[DOI] [PubMed] [Google Scholar] [111]
PMID: 66 BrettoEUrpi-FerreruelaMCasanovaGRGonzalez-SuarezB
J Computat Chem
